Maximilian Schmeding

Papers

1

Total Citations

5

H-Index

1

About

Dr. Maximilian Schmeding is a leading hepatobiliary surgeon whose research focuses on refining surgical outcomes for primary and secondary liver malignancies. His work critically examines the role of lymphadenectomy (LAD) during hepatic resections, particularly for cholangiocarcinoma, hepatocellular carcinoma, and colorectal liver metastases. Drawing on data from the StuDoQ|Liver registry, his 2024 study provides essential insights into the modern era of liver surgery, clarifying the clinical use and postoperative safety of simultaneous LAD. With over 5 citations already, this work is shaping best practices for lymph node management in oncologic liver surgery. Dr. Schmeding’s contributions are pivotal for surgeons seeking to balance oncologic radicality with patient recovery, and his registry-based analyses offer robust, real-world evidence that guides clinical decision-making. His research continues to influence the standardization of surgical approaches, making him a key voice in the advancement of hepatobiliary oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 22

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago